University of Bristol
Also known as: Bristol Children's Vaccine Centre | Bristol Haeamatology and Oncology Centre | Bristol Haematology & Oncology Centre | Bristol Haematology & Oncology Centre, Bristol | Bristol Heart Institute at University of Bristol | Bristol Myers Squibb Srl Italia | Bristol Royal Hospital for Children | Bristol Royal Infirmary | Bristol University, UK | Bristol Urological Institute | Hospital of Bristols, UK | Institute of Child Health at University of Bristol | North Bristol NHS Trust | North Bristol NHS Trust/University of Bristol | Univeristy of Bristol | University Hospitals Bristol NHS Foundation Trust | University Hospitals Bristol NHS Trust | University of Bristol | University of Bristol, Bristol, England (UK)
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1989Last known activity
Dec 8, 2025
Timeline
1590s
- Jun 1, 1595
University of Bristol— Founded
Drugs by trial phase (91 distinct, 54 trials)
Phase 4 (29 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (26 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Alcoholism
- Brain Diseases
- Brain Injuries
- Brain Ischemia
- Breast Neoplasms
- Cancer Pain
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Transitional Cell
- Cellulitis
- Central Nervous System Neoplasms
- Colitis
- Colitis, Ulcerative
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diarrhea
- Epilepsy
- Femoral Fractures
- Femoral Neck Fractures
- Fractures, Bone
- Giant Cell Arteritis
- Glioblastoma
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- Hypertension
- Hypertension, Pulmonary
- Hypoxia-Ischemia, Brain
- Influenza, Human
- Intestinal Neoplasms
- Leukemia
- Leukemia, Lymphoid
- Lung Neoplasms
- Meningococcal Infections
- Myelitis
- Myelitis, Transverse
- Nervous System Neoplasms
- Neuralgia
- Neuralgia, Postherpetic
- Neuromyelitis Optica
- Opioid-Related Disorders
- Osteoarthritis
- Parkinson Disease
- Penile Neoplasms
- Peripheral Nervous System Diseases
- Pneumococcal Infections
- Polymyalgia Rheumatica
- Postpartum Hemorrhage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prediabetic State
- Prostatic Neoplasms
- Purpura, Thrombocytopenic, Idiopathic
- Rhabdomyosarcoma
- Sarcoma
- Schizophrenia
- Sepsis
- Signs and Symptoms
- Thrombocytopenia
- Toxemia
- Ulcer
- Urinary Bladder Diseases
- Urinary Bladder, Overactive
- Urinary Tract Infections
- Urological Manifestations
- Urologic Diseases
- Uveitis
Recent trials (50)
- NCT07134556OfficialPhase 2Dec 8, 2025
- NCT06612203OfficialPhase 1/Phase 2Jan 31, 2025
- NCT06159504CollaboratorEarly Phase 1Mar 31, 2024
- NCT05248919CollaboratorN/AJun 1, 2023
- NCT05453968Overall official - principal investigatorPhase 3Oct 25, 2022
- NCT04226248Lead sponsorPhase 3Jan 2, 2020
- NCT04226248Overall official - principal investigatorPhase 3Jan 2, 2020
- NCT03949764CollaboratorPhase 4Aug 21, 2019
- NCT03865953Overall official - principal investigatorPhase 2Apr 9, 2019
- NCT03821610Study chairPhase 2Nov 22, 2018
- NCT03542461CollaboratorPhase 3Sep 25, 2017
- NCT03156452Study directorPhase 3Sep 1, 2017
- NCT03156452Lead sponsorPhase 3Sep 1, 2017
- NCT03027908Overall official - principal investigatorN/AOct 19, 2016
- NCT02881528CollaboratorPhase 4Mar 1, 2016
Details
- Founded
- Bristol, GB Jun 1, 1595
- Last known activity
- Dec 8, 2025